These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29045910)

  • 21. Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant.
    Khademi F; Sahebkar A; Fasihi-Ramandi M; Taheri RA
    APMIS; 2018 Jun; 126(6):509-514. PubMed ID: 29924445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potentiation of Th1-Type Immune Responses to
    Ko A; Wui SR; Ryu JI; Lee YJ; Hien DTT; Rhee I; Shin SJ; Park SA; Kim KS; Cho YJ; Lee NG
    J Microbiol Biotechnol; 2018 Jan; 28(1):136-144. PubMed ID: 29081214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunity and protective effects of antigen 85A and heat-shock protein X against progressive tuberculosis.
    Jeon BY; Kim SC; Eum SY; Cho SN
    Microbes Infect; 2011 Mar; 13(3):284-90. PubMed ID: 21093603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development and preliminary evaluation of a new Mycobacterium tuberculosis vaccine comprising Ag85b, HspX and CFP-10:ESAT-6 fusion protein with CpG DNA and aluminum hydroxide adjuvants.
    Chen L; Xu M; Wang ZY; Chen BW; Du WX; Su C; Shen XB; Zhao AH; Dong N; Wang YJ; Wang GZ
    FEMS Immunol Med Microbiol; 2010 Jun; 59(1):42-52. PubMed ID: 20298499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.
    Hovav AH; Fishman Y; Bercovier H
    Infect Immun; 2005 Jan; 73(1):250-7. PubMed ID: 15618161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-2 Restores T-Cell Dysfunction Induced by Persistent
    Liu X; Li F; Niu H; Ma L; Chen J; Zhang Y; Peng L; Gan C; Ma X; Zhu B
    Front Immunol; 2019; 10():2350. PubMed ID: 31632413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunogenicity of HspX/EsxS fusion protein of Mycobacterium tuberculosis along with ISCOMATRIX and PLUSCOM nano-adjuvants after subcutaneous administration in animal model.
    Yousefi Avarvand A; Meshkat Z; Khademi F; Tafaghodi M
    Microb Pathog; 2021 May; 154():104842. PubMed ID: 33762199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection.
    Yuan X; Teng X; Jing Y; Ma J; Tian M; Yu Q; Zhou L; Wang R; Wang W; Li L; Fan X
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10587-95. PubMed ID: 26363555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
    Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
    J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis.
    Cai H; Tian X; Hu XD; Zhuang YH; Zhu YX
    DNA Cell Biol; 2004 Jul; 23(7):450-6. PubMed ID: 15294094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthetic Long Peptide Derived from Mycobacterium tuberculosis Latency Antigen Rv1733c Protects against Tuberculosis.
    Coppola M; van den Eeden SJ; Wilson L; Franken KL; Ottenhoff TH; Geluk A
    Clin Vaccine Immunol; 2015 Sep; 22(9):1060-9. PubMed ID: 26202436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in mice.
    Kao FF; Mahmuda S; Pinto R; Triccas JA; West NP; Britton WJ
    PLoS One; 2012; 7(5):e34991. PubMed ID: 22567094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice.
    Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH
    Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and Protective Efficacy of a Fusion Protein Tuberculosis Vaccine Combining Five Esx Family Proteins.
    Xiang ZH; Sun RF; Lin C; Chen FZ; Mai JT; Liu YX; Xu ZY; Zhang L; Liu J
    Front Cell Infect Microbiol; 2017; 7():226. PubMed ID: 28620588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A single vaccination with protein-microspheres elicits a strong CD8 T-cell-mediated immune response against Mycobacterium tuberculosis antigen Mtb8.4.
    Evans JT; Ward JR; Kern J; Johnson ME
    Vaccine; 2004 May; 22(15-16):1964-72. PubMed ID: 15121309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IL-28B down-regulates regulatory T cells but does not improve the protective immunity following tuberculosis subunit vaccine immunization.
    Luo Y; Ma X; Liu X; Lu X; Niu H; Yu H; Bai C; Peng J; Xian Q; Wang Y; Zhu B
    Int Immunol; 2016 Feb; 28(2):77-85. PubMed ID: 26521300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and protective efficacy of DMT liposome-adjuvanted tuberculosis subunit CTT3H vaccine.
    Teng X; Tian M; Li J; Tan S; Yuan X; Yu Q; Jing Y; Zhang Z; Yue T; Zhou L; Fan X
    Hum Vaccin Immunother; 2015; 11(6):1456-64. PubMed ID: 25905680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective Vaccine Efficacy of the Complete Form of PPE39 Protein from Mycobacterium tuberculosis Beijing/K Strain in Mice.
    Kim A; Hur YG; Gu S; Cho SN
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system.
    Meerak J; Wanichwecharungruang SP; Palaga T
    Vaccine; 2013 Jan; 31(5):784-90. PubMed ID: 23228812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
    Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
    Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.